0001209191-23-012875.txt : 20230224
0001209191-23-012875.hdr.sgml : 20230224
20230224182036
ACCESSION NUMBER: 0001209191-23-012875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230224
DATE AS OF CHANGE: 20230224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alspaugh Jonathan
CENTRAL INDEX KEY: 0001868112
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 23669270
MAIL ADDRESS:
STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC.
STREET 2: 805 LAS CIMAS PARKWAY, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-23
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001868112
Alspaugh Jonathan
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100
AUSTIN
TX
78746
0
1
0
0
Chief Financial Officer
Employee Stock Option (right to buy)
0.44
2023-02-23
4
A
0
640000
0.00
A
2033-02-22
Common Stock
640000
640000
D
The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 23, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ James Kastenmayer, by power of attorney
2023-02-24